Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCRT2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | ZBTB7B | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | GPR89B | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | ZNF532 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | LRRC34 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MAATS1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | JPH4 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
mRNA | SNN | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |